id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DOT-OST-2016-0189-0072,DOT,DOT-OST-2016-0189,Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Certain Schedule II Drugs to the Department of Transportation's Drug-Testing Panel and Certain Minor Amendments,Rule,Final Rule,2017-11-13T05:00:00Z,2017,11,2017-11-13T05:00:00Z,,2024-11-07T01:10:29Z,2017-24397,1,0,0900006482c6a2db
DOT-OST-2016-0189-0071,DOT,DOT-OST-2016-0189,Laboratory Corporation of America Holdings (Correspondence),Other,Correspondence,2017-08-30T04:00:00Z,2017,8,2017-08-30T04:00:00Z,,2017-08-30T18:45:31Z,,0,0,0900006482af6a0f
DOT-OST-2016-0189-0001,DOT,DOT-OST-2016-0189,Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Certain Schedule II Drugs to the Drug-Testing Panel and Certain Minor Amendments,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2017-01-23T05:00:00Z,2017,1,2017-01-23T05:00:00Z,2017-03-25T03:59:59Z,2017-03-25T13:00:52Z,2017-01131,0,0,090000648248914b